Study Details How Cancer Cells Fend Off Starvation & Death from Chemotherapy | NYU Langone News
We use cookies and similar tools to give you the best website experience. By using our site, you accept our Websites Privacy Policy .
The new study, led by researchers that included Dr. Richard L. Possemato, looked at how cancer cells are able to survive when there’s a shortage of glucose.
Laboratory experiments with cancer cells reveal two ways in which tumors evade drugs designed to starve and kill them, a new study shows.
Although chemotherapies successfully treat cancers and extend patients’ lives, they are known not to work for everyone for long, as cancer cells rewire the process by which they convert fuel into energy (metabolism) to outmaneuver the drugs’ effects. Many of these drugs are so-called antimetabolics, disrupting cell processes needed for tumor growth and survival.
Three such drugs used in the study—raltitrexed, N-(phosphonacetyl)-l-aspartate (PALA), and brequinar—work to prevent cancer cells from making pyrimidines, molecules that are an essential component to genetic letter codes, meaning nucleotides, that make up RNA and DNA. Cancer cells must have access to pyrimidine supplies to produce more cancer cells and to produce uridine nucleotides, a primary fuel source for cancer cells as they rapidly reproduce, grow, and die. Disrupting the fast-paced but fragile pyrimidine synthesis pathways, as some chemotherapies are designed to do, can rapidly starve cancer cells and spontaneously lead to them dying (apoptosis).
